Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Clinical trial NCT01242774 · COMPLETED
Trial details
- NCT number
- NCT01242774
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.